Singulus bags another HJT order

Singulus Technologies AG has secured an order for the supply of its heterojunction (HJT) solar cell production equipment. The contract for the production line of the type Silex II and the delivery of the new sputtering system Generis PVD was signed in recent days, said the PV supplier from Kahl am Main on Monday. The payment for the equipment is still pending, the company added, but it is expected to be made soon. The customer comes from China, a Singulus spokesperson told pv magazine. The company, however, has not provided details on the order volume and the customer’s name.

Singlusus said this is the first order for its newly developed sputtering system. According to the company, the solar cells are automatically transported through the process chambers and coated on both sides. “The GENERIS PVD ensures a high level of uniformity in terms of layer thickness amid a level of reproducibility of the layer with highest efficiency and low operating costs,” it said, adding that the production line was designed specifically for very thin substrates, such as wafers for the production of HJT solar cells.

Singulus has also invested heavily in the development of Silex process equipment. With the improved version, photovoltaic manufacturers may manufacture much more cost-effectively, compared to conventional systems thanks to the use of ozone, the company claims.

In October, Singulus announced the formation of a joint venture with the two Chinese photovoltaic companies Golden Concord Holdings Limited (GCL) and China Intellectual Electric Power Technology Co., Ltd. (CIE). Through the joint venture, Singulus is aiming to develop, optimize, build and distribute complete production lines to produce high-efficiency HJT solar cells.

Meanwhile, at the end of last week, the company announced a capital increase of up to 10% through the issuance of new shares. At a meeting on Wednesday, the Executive Board will inform shareholders about the planned strengthening of the equity base and other future prospects. In addition to improving equity, the capital increase also serves to finance current and expected order intake.